Zai Lab Announces Upcoming Presentations in June Investor Conferences

SHANGHAI and SAN FRANCISCO, May 25, 2021 (GLOBE NEWSWIRE) -- Zai Lab Limited (“Zai Lab”) (NASDAQ: ZLAB; HKEX: 9688), an innovative commercial-stage biopharmaceutical company, today announced that management from Zai Lab will be presenting at the following upcoming virtual investor conferences in June:

Jefferies Healthcare Conference 2021Presentation: Wednesday, June 2, 2021 at 10:00 a.m. EDT

J.P. Morgan Global China Summit Panel Discussion: Thursday, June 3, 2021 at 10:45 a.m. HKT

Goldman Sachs 42nd Annual Global Healthcare ConferenceFireside Chat: Tuesday, June 8, 2021 at 8:50 a.m. EDT

Live webcasts of the conferences will be available under “Events & Presentations” in the “Investor Relations” section of Zai Lab’s website. An archived replay will be available for 90 days following the event.

About Zai Lab

Zai Lab (NASDAQ: ZLAB; HKEX: 9688) is an innovative, research-based, commercial-stage biopharmaceutical company focused on developing and commercializing therapies that address medical conditions with unmet needs in oncology, autoimmune disorders and infectious disease. To that end, our experienced team has secured partnerships with leading global biopharmaceutical companies in order to generate a broad pipeline of innovative marketed products and product candidates. We have also built an in-house team with strong product discovery and translational research capabilities and are establishing a pipeline of proprietary product candidates with global rights. Our vision is to become a leading global biopharmaceutical company, discovering, developing, manufacturing and commercializing our portfolio in order to impact human health worldwide.

For additional information about the company, please visit www.zailaboratory.com or follow us at www.twitter.com/ZaiLab_Global.

For more information, please contact:

ZAI LAB CONTACTS:

Zai LabBilly Cho, CFO+86 137 6151 2501 [email protected]

Media: Ryo Imai / Robert Flamm, Ph.D.Burns McClellan, on behalf of Zai Lab212-213-0006 ext. 315 / 364[email protected] / [email protected]

Investors: Pete Rahmer / Mike ZanoniEndurance Advisors, on behalf of Zai Lab415-515-9763 / 610-442-8570[email protected] / [email protected]

Zai Lab Limited

Source: Zai Lab Limited

Source: Zai Lab Limited

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Steelworkers back Canada holding the line on trade, call for a stronger response to protect Canadian jobs and industry
• Latest Crypto News: Bitcoin Rips Past $77K, Cardano Turns Bullish – Is Apeing Whitelist the Next Move for Traders? 
• 24/7 Emergency Electrical and Panel Upgrade Services Now in Parkersburg